Increased risk of gastrointestinal acute GVHD following the addition of melphalan to busulfan/cyclophosphamide conditioning. [electronic resource]
Producer: 20140117Description: 285-93 p. digitalISSN:- 1399-3046
- Adolescent
- Busulfan -- administration & dosage
- Child
- Child, Preschool
- Cyclophosphamide -- adverse effects
- Female
- Gastrointestinal Tract -- drug effects
- Graft vs Host Disease -- diagnosis
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Infant
- Leukemia, Myelomonocytic, Acute -- therapy
- Male
- Melphalan -- administration & dosage
- Myelodysplastic Syndromes -- therapy
- Retrospective Studies
- Risk Factors
- Transplantation Conditioning -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.